Insulin secretion and insulin sensitivity in relation to glucose tolerance

Lessons from the Botnia Study

Devjit Tripathy, Martin Carlsson, Peter Almgren, Bo Isomaa, Marja Riitta Taskinen, Tiinamaija Tuomi, Leif C. Groop

Research output: Contribution to journalArticle

281 Citations (Scopus)

Abstract

Recently, a new stage in glucose tolerance, impaired fasting glucose (IFG) (fasting plasma glucose level of 6.1-6.9 mmol/l), was introduced in addition to impaired glucose tolerance (IGT) (2-h glucose level of 7.8-11.0 mmol/l). It is not clear whether IFG and IGT differ with respect to insulin secretion or sensitivity. To address this question, we estimated insulin secretion (by measuring both insulin levels and the ratio of insulin-to- glucose levels in 30-min intervals) and insulin sensitivity (by using the homeostasis model assessment [HOMA] index) from an oral glucose tolerance test (OGTT) in 5,396 individuals from the Botnia Study who had varying degrees of glucose tolerance. There was poor concordance between IFG and IGT: only 36% (303 of 840) of the subjects with IFG had IGT, whereas 62% (493 of 796) of the subjects with IGT did not have IFG. Compared with subjects with normal glucose tolerance (NGT), subjects with IFG were more insulin resistant (HOMA-insulin resistance [IR] values 2.64 ± 0.08 vs. 1.73 ± 0.03, P < 0.0005), had greater insulin responses during an OGTT (P = 0.0001), had higher waist-to-hip ratios (P < 0.005), had higher triglyceride and total cholesterol concentrations (P < 0.0005), and had lower HDL cholesterol concentrations (P = 0.0001)> Compared with subjects with IFG, subjects with IGT had a lower incremental 30-min insulin-to-glucose area during an OGTT (13.8 ± 1.7 vs. 21.7 ± 1.7, P = 0.0008). Compared with subjects with IGT, subjects with mild diabetes (fasting plasma glucose levels <7.8 mmol/l) showed markedly impaired insulin secretion that could no longer compensate for IR and elevated glucose levels. A progressive decline in insulin sensitivity was observed when moving from NGT to IGT and to subjects with diabetes (P < 0.05 for trend), whereas insulin secretion followed an inverted U-shaped form. We conclude that IFG is characterized by basal IR and other features of the metabolic syndrome, whereas subjects with IGT have impaired insulin secretion in relation to glucose concentrations. An absolute decompensation of β-cell function characterizes the transition from IGT to mild diabetes.

Original languageEnglish (US)
Pages (from-to)975-980
Number of pages6
JournalDiabetes
Volume49
Issue number6
StatePublished - Jun 2000
Externally publishedYes

Fingerprint

Insulin Resistance
Glucose Intolerance
Insulin
Glucose
Fasting
Glucose Tolerance Test
Homeostasis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M. R., Tuomi, T., & Groop, L. C. (2000). Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the Botnia Study. Diabetes, 49(6), 975-980.

Insulin secretion and insulin sensitivity in relation to glucose tolerance : Lessons from the Botnia Study. / Tripathy, Devjit; Carlsson, Martin; Almgren, Peter; Isomaa, Bo; Taskinen, Marja Riitta; Tuomi, Tiinamaija; Groop, Leif C.

In: Diabetes, Vol. 49, No. 6, 06.2000, p. 975-980.

Research output: Contribution to journalArticle

Tripathy, D, Carlsson, M, Almgren, P, Isomaa, B, Taskinen, MR, Tuomi, T & Groop, LC 2000, 'Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the Botnia Study', Diabetes, vol. 49, no. 6, pp. 975-980.
Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the Botnia Study. Diabetes. 2000 Jun;49(6):975-980.
Tripathy, Devjit ; Carlsson, Martin ; Almgren, Peter ; Isomaa, Bo ; Taskinen, Marja Riitta ; Tuomi, Tiinamaija ; Groop, Leif C. / Insulin secretion and insulin sensitivity in relation to glucose tolerance : Lessons from the Botnia Study. In: Diabetes. 2000 ; Vol. 49, No. 6. pp. 975-980.
@article{52148c77a4454135b662646b6d56742f,
title = "Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the Botnia Study",
abstract = "Recently, a new stage in glucose tolerance, impaired fasting glucose (IFG) (fasting plasma glucose level of 6.1-6.9 mmol/l), was introduced in addition to impaired glucose tolerance (IGT) (2-h glucose level of 7.8-11.0 mmol/l). It is not clear whether IFG and IGT differ with respect to insulin secretion or sensitivity. To address this question, we estimated insulin secretion (by measuring both insulin levels and the ratio of insulin-to- glucose levels in 30-min intervals) and insulin sensitivity (by using the homeostasis model assessment [HOMA] index) from an oral glucose tolerance test (OGTT) in 5,396 individuals from the Botnia Study who had varying degrees of glucose tolerance. There was poor concordance between IFG and IGT: only 36{\%} (303 of 840) of the subjects with IFG had IGT, whereas 62{\%} (493 of 796) of the subjects with IGT did not have IFG. Compared with subjects with normal glucose tolerance (NGT), subjects with IFG were more insulin resistant (HOMA-insulin resistance [IR] values 2.64 ± 0.08 vs. 1.73 ± 0.03, P < 0.0005), had greater insulin responses during an OGTT (P = 0.0001), had higher waist-to-hip ratios (P < 0.005), had higher triglyceride and total cholesterol concentrations (P < 0.0005), and had lower HDL cholesterol concentrations (P = 0.0001)> Compared with subjects with IFG, subjects with IGT had a lower incremental 30-min insulin-to-glucose area during an OGTT (13.8 ± 1.7 vs. 21.7 ± 1.7, P = 0.0008). Compared with subjects with IGT, subjects with mild diabetes (fasting plasma glucose levels <7.8 mmol/l) showed markedly impaired insulin secretion that could no longer compensate for IR and elevated glucose levels. A progressive decline in insulin sensitivity was observed when moving from NGT to IGT and to subjects with diabetes (P < 0.05 for trend), whereas insulin secretion followed an inverted U-shaped form. We conclude that IFG is characterized by basal IR and other features of the metabolic syndrome, whereas subjects with IGT have impaired insulin secretion in relation to glucose concentrations. An absolute decompensation of β-cell function characterizes the transition from IGT to mild diabetes.",
author = "Devjit Tripathy and Martin Carlsson and Peter Almgren and Bo Isomaa and Taskinen, {Marja Riitta} and Tiinamaija Tuomi and Groop, {Leif C.}",
year = "2000",
month = "6",
language = "English (US)",
volume = "49",
pages = "975--980",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Insulin secretion and insulin sensitivity in relation to glucose tolerance

T2 - Lessons from the Botnia Study

AU - Tripathy, Devjit

AU - Carlsson, Martin

AU - Almgren, Peter

AU - Isomaa, Bo

AU - Taskinen, Marja Riitta

AU - Tuomi, Tiinamaija

AU - Groop, Leif C.

PY - 2000/6

Y1 - 2000/6

N2 - Recently, a new stage in glucose tolerance, impaired fasting glucose (IFG) (fasting plasma glucose level of 6.1-6.9 mmol/l), was introduced in addition to impaired glucose tolerance (IGT) (2-h glucose level of 7.8-11.0 mmol/l). It is not clear whether IFG and IGT differ with respect to insulin secretion or sensitivity. To address this question, we estimated insulin secretion (by measuring both insulin levels and the ratio of insulin-to- glucose levels in 30-min intervals) and insulin sensitivity (by using the homeostasis model assessment [HOMA] index) from an oral glucose tolerance test (OGTT) in 5,396 individuals from the Botnia Study who had varying degrees of glucose tolerance. There was poor concordance between IFG and IGT: only 36% (303 of 840) of the subjects with IFG had IGT, whereas 62% (493 of 796) of the subjects with IGT did not have IFG. Compared with subjects with normal glucose tolerance (NGT), subjects with IFG were more insulin resistant (HOMA-insulin resistance [IR] values 2.64 ± 0.08 vs. 1.73 ± 0.03, P < 0.0005), had greater insulin responses during an OGTT (P = 0.0001), had higher waist-to-hip ratios (P < 0.005), had higher triglyceride and total cholesterol concentrations (P < 0.0005), and had lower HDL cholesterol concentrations (P = 0.0001)> Compared with subjects with IFG, subjects with IGT had a lower incremental 30-min insulin-to-glucose area during an OGTT (13.8 ± 1.7 vs. 21.7 ± 1.7, P = 0.0008). Compared with subjects with IGT, subjects with mild diabetes (fasting plasma glucose levels <7.8 mmol/l) showed markedly impaired insulin secretion that could no longer compensate for IR and elevated glucose levels. A progressive decline in insulin sensitivity was observed when moving from NGT to IGT and to subjects with diabetes (P < 0.05 for trend), whereas insulin secretion followed an inverted U-shaped form. We conclude that IFG is characterized by basal IR and other features of the metabolic syndrome, whereas subjects with IGT have impaired insulin secretion in relation to glucose concentrations. An absolute decompensation of β-cell function characterizes the transition from IGT to mild diabetes.

AB - Recently, a new stage in glucose tolerance, impaired fasting glucose (IFG) (fasting plasma glucose level of 6.1-6.9 mmol/l), was introduced in addition to impaired glucose tolerance (IGT) (2-h glucose level of 7.8-11.0 mmol/l). It is not clear whether IFG and IGT differ with respect to insulin secretion or sensitivity. To address this question, we estimated insulin secretion (by measuring both insulin levels and the ratio of insulin-to- glucose levels in 30-min intervals) and insulin sensitivity (by using the homeostasis model assessment [HOMA] index) from an oral glucose tolerance test (OGTT) in 5,396 individuals from the Botnia Study who had varying degrees of glucose tolerance. There was poor concordance between IFG and IGT: only 36% (303 of 840) of the subjects with IFG had IGT, whereas 62% (493 of 796) of the subjects with IGT did not have IFG. Compared with subjects with normal glucose tolerance (NGT), subjects with IFG were more insulin resistant (HOMA-insulin resistance [IR] values 2.64 ± 0.08 vs. 1.73 ± 0.03, P < 0.0005), had greater insulin responses during an OGTT (P = 0.0001), had higher waist-to-hip ratios (P < 0.005), had higher triglyceride and total cholesterol concentrations (P < 0.0005), and had lower HDL cholesterol concentrations (P = 0.0001)> Compared with subjects with IFG, subjects with IGT had a lower incremental 30-min insulin-to-glucose area during an OGTT (13.8 ± 1.7 vs. 21.7 ± 1.7, P = 0.0008). Compared with subjects with IGT, subjects with mild diabetes (fasting plasma glucose levels <7.8 mmol/l) showed markedly impaired insulin secretion that could no longer compensate for IR and elevated glucose levels. A progressive decline in insulin sensitivity was observed when moving from NGT to IGT and to subjects with diabetes (P < 0.05 for trend), whereas insulin secretion followed an inverted U-shaped form. We conclude that IFG is characterized by basal IR and other features of the metabolic syndrome, whereas subjects with IGT have impaired insulin secretion in relation to glucose concentrations. An absolute decompensation of β-cell function characterizes the transition from IGT to mild diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0034128587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034128587&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 975

EP - 980

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -